List of Tables
    Table 1. Epilepsy Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Epilepsy Drugs Market Trends
    Table 3. Epilepsy Drugs Market Drivers
    Table 4. Epilepsy Drugs Market Challenges
    Table 5. Epilepsy Drugs Market Restraints
    Table 6. Global Epilepsy Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Epilepsy Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Epilepsy Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Epilepsy Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Epilepsy Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Epilepsy Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Epilepsy Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Epilepsy Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Epilepsy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2021)
    Table 15. Top Players of Epilepsy Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Epilepsy Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Epilepsy Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Epilepsy Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Epilepsy Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Epilepsy Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Epilepsy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Epilepsy Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Epilepsy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Epilepsy Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Epilepsy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Epilepsy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Epilepsy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Laboratories Company Details
    Table 31. Abbott Laboratories Business Overview
    Table 32. Abbott Laboratories Epilepsy Drugs Product
    Table 33. Abbott Laboratories Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 34. Abbott Laboratories Recent Development
    Table 35. GlaxoSmithKline Plc Company Details
    Table 36. GlaxoSmithKline Plc Business Overview
    Table 37. GlaxoSmithKline Plc Epilepsy Drugs Product
    Table 38. GlaxoSmithKline Plc Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 39. GlaxoSmithKline Plc Recent Development
    Table 40. UCB Company Details
    Table 41. UCB Business Overview
    Table 42. UCB Epilepsy Drugs Product
    Table 43. UCB Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 44. UCB Recent Development
    Table 45. Cephalon Company Details
    Table 46. Cephalon Business Overview
    Table 47. Cephalon Epilepsy Drugs Product
    Table 48. Cephalon Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 49. Cephalon Recent Development
    Table 50. Johnson & Johnson Company Details
    Table 51. Johnson & Johnson Business Overview
    Table 52. Johnson & Johnson Epilepsy Drugs Product
    Table 53. Johnson & Johnson Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 54. Johnson & Johnson Recent Development
    Table 55. Pfizer Company Details
    Table 56. Pfizer Business Overview
    Table 57. Pfizer Epilepsy Drugs Product
    Table 58. Pfizer Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. Novartis AG Company Details
    Table 61. Novartis AG Business Overview
    Table 62. Novartis AG Epilepsy Drugs Product
    Table 63. Novartis AG Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 64. Novartis AG Recent Development
    Table 65. Abbvie Company Details
    Table 66. Abbvie Business Overview
    Table 67. Abbvie Epilepsy Drugs Product
    Table 68. Abbvie Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 69. Abbvie Recent Development
    Table 70. Janssen Pharmaceuticals Company Details
    Table 71. Janssen Pharmaceuticals Business Overview
    Table 72. Janssen Pharmaceuticals Epilepsy Drugs Product
    Table 73. Janssen Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 74. Janssen Pharmaceuticals Recent Development
    Table 75. Sunovion Pharmaceuticals Company Details
    Table 76. Sunovion Pharmaceuticals Business Overview
    Table 77. Sunovion Pharmaceuticals Epilepsy Drugs Product
    Table 78. Sunovion Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 79. Sunovion Pharmaceuticals Recent Development
    Table 80. Bausch Health Company Details
    Table 81. Bausch Health Business Overview
    Table 82. Bausch Health Epilepsy Drugs Product
    Table 83. Bausch Health Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 84. Bausch Health Recent Development
    Table 85. Sanofi S.A Company Details
    Table 86. Sanofi S.A Business Overview
    Table 87. Sanofi S.A Epilepsy Drugs Product
    Table 88. Sanofi S.A Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 89. Sanofi S.A Recent Development
    Table 90. Takeda Company Details
    Table 91. Takeda Business Overview
    Table 92. Takeda Epilepsy Drugs Product
    Table 93. Takeda Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 94. Takeda Recent Development
    Table 95. Eisai Company Details
    Table 96. Eisai Business Overview
    Table 97. Eisai Epilepsy Drugs Product
    Table 98. Eisai Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 99. Eisai Recent Development
    Table 100. F. Hoffmann-La Roche Company Details
    Table 101. F. Hoffmann-La Roche Business Overview
    Table 102. F. Hoffmann-La Roche Epilepsy Drugs Product
    Table 103. F. Hoffmann-La Roche Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
    Table 104. F. Hoffmann-La Roche Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Epilepsy Drugs Product Picture
    Figure 2. Global Epilepsy Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Epilepsy Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Epilepsy Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Epilepsy Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Epilepsy Drugs Market Share in Global 2017-2028
    Figure 7. Epilepsy Drugs Report Years Considered
    Figure 8. Product Picture of First Generation
    Figure 9. Product Picture of Second Generation
    Figure 10. Global Epilepsy Drugs Market Share by Type in 2022 & 2028
    Figure 11. Global Epilepsy Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Epilepsy Drugs Market Share by Type (2017-2028)
    Figure 13. United States Epilepsy Drugs Market Share by Type in 2022 & 2028
    Figure 14. United States Epilepsy Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Epilepsy Drugs Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital Pharmacies
    Figure 17. Product Picture of Retail Pharmacies
    Figure 18. Product Picture of Online Pharmacies
    Figure 19. Global Epilepsy Drugs Market Share by Application in 2022 & 2028
    Figure 20. Global Epilepsy Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Epilepsy Drugs Market Share by Application (2017-2028)
    Figure 22. United States Epilepsy Drugs Market Share by Application in 2022 & 2028
    Figure 23. United States Epilepsy Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Epilepsy Drugs Market Share by Application (2017-2028)
    Figure 25. North America Epilepsy Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Epilepsy Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Epilepsy Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Epilepsy Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Epilepsy Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Epilepsy Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Abbott Laboratories Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 54. GlaxoSmithKline Plc Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 55. UCB Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 56. Cephalon Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 59. Novartis AG Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 60. Abbvie Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 61. Janssen Pharmaceuticals Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 62. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 63. Bausch Health Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 64. Sanofi S.A Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 65. Takeda Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 66. Eisai Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed